BRAF and colorectal carcinoma: BRAF mutations in CRC are associated with more aggressive disease and poor outcome through associations with pathological features (poorly differentiated tumors, tumor budding), advanced disease stage at the time of diagnosis, and peritoneal metastasis [38].